McGill team funded as part of a $4.5 million national investment dedicated to identifying genomic solutions to counter antimicrobial resistance and prepare for future pandemics
Multidisciplinary unit to focus on rise of ‘superbugs’ identified by WHO as a leading threat to global health, responsible for 700,000 annual deaths worldwide
October 20, 2021 (Montreal, Quebec) – Globally, Antimicrobial Resistance (AMR) causes approximately 700,000 deaths annually, a number projected to reach over The prevalence of AMR in Canada is projected to reach 40% by this time, a plausible scenario if no interventions successfully curb their rise.
On May 3, the announced the recent recipients of the NSERC Strategic Partnership Grants program. Six McGill-led projects in the Faculty of Engineering and one in the Faculty of Medicine are receiving more than $3.7 million to conduct research in collaboration with a supporting organization.